Delivery Order SPE2DB25D3404-SPE2DB25FUMAL
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 40mg capsules. The contract has a total ceiling value of $3,970.91 and runs through October 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 10 mg capsules. The contract has a ceiling value of $2,728.02 and a completion date of December 10, 2024. It is a firm fixed-price contract and was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,357,935 units of the prescription drug Vyvanse (40 mg capsules) with a ceiling value of $1,338.92. The contract has a firm fixed price pricing type and an ultimate completion date of November 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,781.26 firm fixed-price contract is for the delivery of Vyvanse 20 mg capsules, a prescription medication. The contract has an ultimate completion date of October 18, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The contract has a ceiling value of $1,795.91 and a completion date of January 3, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,343.21 firm fixed price contract is for the supply of Vyvanse 70 mg capsules in 100-count packages. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies to supply a wide range of pharmaceutical and medical products, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a ceiling value of $1,496.10 and is set to expire on April 19, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a ceiling value of $1,165.58 and a completion date of January 7, 2025. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 70mg capsules. The contract has an ultimate completion date of January 9, 2025 and a ceiling value of $2,043.85. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,110,605 units of the pharmaceutical drug Vyvanse 40 mg capsule. The contract has a total ceiling value of $4,796.63 and a completion date of October 16, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...